Venneos, a Germany-based biotech spinout of research network Max Planck Society, has obtained an undisclosed sum from the organisation’s tech transfer arm Max Planck Innovation.
The round also featured German public-private partnership High-Tech Gründerfonds, venture capital fund Born2Grow and unnamed family offices and angel investors.
Founded in 2013, Venneos has developed cellular analysis technology that collects electrical signals from cell mutations on a silicon chip, providing a more accurate picture for researchers of new technologies.
The technology was developed at…
